Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome

BackgroundThis study aims to investigate the prognostic significance of transthyretin in newly diagnosed myelodysplastic syndromes (MDS).MethodsThe clinical, laboratory, and follow-up data of 280 newly diagnosed patients with MDS were collected. The relationship between serum transthyretin levels an...

Full description

Bibliographic Details
Main Authors: Ying Chen, Tingting Niu, Ting Chen, Yue Wu, Duobing Zou, Cong Shi, Ying Wu, Zhaoyi Zhang, Ningning Wu, Yi Zhang, Xiao Yan, Lixia Sheng, Dingfeng Lv, Guifang Ouyang, Xueqin Chen, Qitian Mu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Nutrition
Subjects:
myelodysplastic syndromes
transthyretin
prognosis
IPSS-R
IPSS-M
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1125768/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2023.1125768/full

Similar Items